Activation of hepatic NF-kappaB by phenobarbital in rats

Biochem Biophys Res Commun. 1996 Dec 24;229(3):982-9. doi: 10.1006/bbrc.1996.1911.

Abstract

Nuclear factor kappaB (NF-kappaB) is an important stress-induced transcription factor in many cell types. In this study we examined if the hepatic tumor promoting agent phenobarbital could activate NF-kappaB in the liver. Rats were fed 0.05% phenobarbital in the diet for 3, 6, or 10 days. Benzyloxyresorufin dealkylase activity was greatly increased in rats receiving phenobarbital. The DNA binding activity of NF-kappaB was determined using electrophoretic mobility shift assays. After 3 days, NF-kappaB activity was increased two-fold in rats receiving phenobarbital. NF-kappaB activity continued to increase at 6 and 10 days in rats fed phenobarbital, with a four-fold increase seen at day 10. Cold competition and antibody supershift experiments showed the DNA binding activity to be specific for NF-kappaB. These data show that phenobarbital activates hepatic NF-kappaB in rats.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Gene Expression Regulation / drug effects
  • Liver / metabolism*
  • Male
  • NF-kappa B / metabolism*
  • Phenobarbital / pharmacology*
  • Rats
  • Rats, Sprague-Dawley

Substances

  • NF-kappa B
  • Phenobarbital